chang fair valu estim
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research feb
estim oct
price data jan
rate updat jan
currenc amount express
methodolog valu compani
zimmer biomet report fourth-quart perform
demonstr consist increment progress
toward address suppli regulatori cultur
issu hamper firm last two year
unchang full-year
perform gener met expect continu
anticip gradual return growth improv
profit longer term though still think larg
joint growth lag market nonetheless
think new manag method address key
weak dysfunct sinc ceo bryan hanson join
firm one year ago hanson attent shore
fundament oper leav firm well posit
take advantag wide econom moat stem
issu caught attent come earn
call first firm indic work
remedi plan legaci biomet plant
readi reinspect end year consid
fda first rais issu facil late time
necessari resolv issu move beyond
origin expect two year howev
consider optimist situat
last spring follow fda reinspect
repeat number origin observ longer
time frame remedi suggest zimmer biomet
devot time resourc fulli address regulatori
total knee replac indic rosa robot
weve discuss mako robot
instrument impress knee growth
last two year expect addit rosa zimmer
biomet arsen help firm boost growth
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
zimmer biomet design manufactur market orthoped
reconstruct implant well suppli surgic equip
orthoped surgeri acquisit centerpuls biomet
zimmer hold lead share reconstruct market
unit state europ japan distribut sell product
hospit clinic world-wide brand name like nexgen zimmer
versi soplu pulsavac
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
knee franchis first six month soft launch
mute grow strength head
sinc ramp placement mako robot
zimmer biomet johnson johnson born
brunt anem knee sale trail market growth
weve point market share shift
orthoped market tend glacial best due
high switch cost surgeon global basi
estim zimmer biomet lost roughli basi
point market share dollar basi though still own
largest share knee implant dollar surmis
shift may acut market
mako placement thu particularli
intrigu manag comment suggest zimmer
biomet share loss volum appear less
dollar share loss impli number procedur
use zimmer biomet knee may hold rel
well abl grow knee revenu
sell expens implant portfolio
case zimmer biomet strong posit
roll rosa robot base surgeon alreadi
favor firm product pivot robot-
driven opportun
final look forward see initi clinic data
mako robot upcom orthoped confer
find posit zimmer biomet could see acceler
placement rosa robot year
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
